清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Evolution of Transarterial Chemoembolization for the Treatment of Liver Cancer

医学 梅德林 肝细胞癌 核医学 放射科 医学物理学 内科学 法学 政治学
作者
Kyung Won Kim,Annick D. Van den Abbeele
出处
期刊:Radiology [Radiological Society of North America]
卷期号:293 (3): 704-706 被引量:9
标识
DOI:10.1148/radiol.2019192090
摘要

HomeRadiologyVol. 293, No. 3 PreviousNext Reviews and CommentaryEditorialEvolution of Transarterial Chemoembolization for the Treatment of Liver CancerKyung Won Kim , Annick D. Van den AbbeeleKyung Won Kim , Annick D. Van den AbbeeleAuthor AffiliationsFrom the Department of Radiology and Research Institute of Radiology, Asan Image Metrics, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu Seoul 138-736, Republic of Korea (K.W.K.); and Department of Imaging and Center for Biomedical Imaging in Oncology, Dana-Farber Cancer Institute; Department of Radiology, Brigham Health, Harvard Medical School, Boston, Mass (A.D.V.d.A.).Address correspondence to K.W.K. (e-mail: [email protected], [email protected]).Kyung Won Kim Annick D. Van den AbbeelePublished Online:Oct 15 2019https://doi.org/10.1148/radiol.2019192090MoreSectionsFull textPDF ToolsAdd to favoritesCiteTrack CitationsPermissionsReprints ShareShare onFacebookXLinked In References1. Pesapane F, Nezami N, Patella F, Geschwind JF. New concepts in embolotherapy of HCC. Med Oncol 2017;34(4):58. Crossref, Medline, Google Scholar2. Viveiros P, Riaz A, Lewandowski RJ, Mahalingam D. Current State of Liver-Directed Therapies and Combinatory Approaches with Systemic Therapy in Hepatocellular Carcinoma (HCC). Cancers (Basel) 2019;11(8):E1085. Crossref, Medline, Google Scholar3. Suk Oh J, Jong Chun H, Gil Choi B, Giu Lee H. Transarterial chemoembolization with drug-eluting beads in hepatocellular carcinoma: usefulness of contrast saturation features on cone-beam computed tomography imaging for predicting short-term tumor response. J Vasc Interv Radiol 2013;24(4):483–489. Crossref, Medline, Google Scholar4. Levy EB, Krishnasamy VP, Lewis AL, et al. First Human Experience with Directly Image-able Iodinated Embolization Microbeads. Cardiovasc Intervent Radiol 2016;39(8):1177–1186. Crossref, Medline, Google Scholar5. Zhan P, Qian Q, Yu L-K. Serum VEGF level is associated with the outcome of patients with hepatocellular carcinoma: a meta-analysis. Hepatobiliary Surg Nutr 2013;2(4):209–215. Medline, Google Scholar6. Kudo M, Imanaka K, Chida N, et al. Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma. Eur J Cancer 2011;47(14):2117–2127. Crossref, Medline, Google Scholar7. Lencioni R, Llovet JM, Han G, et al. Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trial. J Hepatol 2016;64(5):1090–1098. Crossref, Medline, Google Scholar8. Meyer T, Fox R, Ma YT, et al. Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial. Lancet Gastroenterol Hepatol 2017;2(8):565–575. Crossref, Medline, Google Scholar9. Kudo M. Proposal of Primary Endpoints for TACE Combination Trials with Systemic Therapy: Lessons Learned from 5 Negative Trials and the Positive TACTICS Trial. Liver Cancer 2018;7(3):225–234. Crossref, Medline, Google Scholar10. Duran R, Namur J, Pascale F, et al. Vandetanib-eluting radiopaque beads: pharmacokinetics, safety, and efficacy in a rabbit model of liver cancer. Radiology 2019;293:695–703. Link, Google ScholarArticle HistoryReceived: Sept 12 2019Revision requested: Sept 23 2019Revision received: Sept 25 2019Accepted: Sept 27 2019Published online: Oct 15 2019Published in print: Dec 2019 FiguresReferencesRelatedDetailsCited ByContrast-Enhanced CT Imaging Features Combined with Clinical Factors to Predict the Efficacy and Prognosis for Transarterial Chemoembolization of Hepatocellular CarcinomaZhongqiSun, ZhongxingShi, YanjieXin, ShengZhao, HaoJiang, JinpingLi, JiapingLi, HuijieJiang2023Sep1 | Academic Radiology, Vol. 30CT/MR detectable magnetic microspheres for self-regulating temperature hyperthermia and transcatheter arterial chemoembolizationChengxiongWei, ChengweiWu, XinJin, PeinanYin, XiaogangYu, ChaoWang, WeiZhang2022 | Acta Biomaterialia, Vol. 153Evaluation of short-term effects of drug-loaded microspheres and traditional transcatheter arterial chemoembolization in the treatment of advanced liver cancerTingYe, Shi-HanShao, KanJi, Shu-LinYao2022 | World Journal of Gastrointestinal Oncology, Vol. 14, No. 12Comparison of DEB-TACE and cTACE for the initial treatment of unresectable hepatocellular carcinoma beyond up-to-seven criteria: A single-center propensity score matching analysisQinShi, JiachengLiu, TongqiangLi, ChenZhou, YingliangWang, SongjiangHuang, ChongtuYang, YangChen, BinXiong2022 | Clinics and Research in Hepatology and Gastroenterology, Vol. 46, No. 5Homoharringtonine Exerts Anti-tumor Effects in Hepatocellular Carcinoma Through Activation of the Hippo PathwayHainaWang, RuiWang, DanHuang, SihanLi, BeibeiGao, ZhijieKang, BoTang, JiajunXie, FanzhiYan, RuiLiang, HuaLi, JinsongYan2021 | Frontiers in Pharmacology, Vol. 12Recommended Articles Can CT Following Chemoembolization with Radiopaque Drug-Eluting Beads Tell Us How Much Drug We Deliver?Radiology2018Volume: 289Issue: 2pp. 405-406Adding Sorafenib-eluting Microspheres to TACE: The Next Step in Hepatocellular Carcinoma TreatmentRadiology: Imaging Cancer2021Volume: 3Issue: 1Transarterial Embolization Modulates the Immune Response within Target and Nontarget Hepatocellular Carcinomas in a Rat ModelRadiology2022Volume: 303Issue: 1pp. 215-225Vandetanib-eluting Radiopaque Beads: Pharmacokinetics, Safety, and Efficacy in a Rabbit Model of Liver CancerRadiology2019Volume: 293Issue: 3pp. 695-703Correlation of Doxorubicin Delivery and Tumor Necrosis after Drug-eluting Bead Transarterial Chemoembolization of Rabbit VX2 Liver TumorsRadiology2016Volume: 280Issue: 3pp. 752-761See More RSNA Education Exhibits Novel Embolic Agents On The HorizonDigital Posters2021Complications Of Locoregional Therapy In The Treatment Of Liver Malignancy: Adverse Events From Common To RareDigital Posters2021Updates on Combination TACE and Ablation Therapy for HCC: A Case-Based Review of Technique, Results and ComplicationsDigital Posters2022 RSNA Case Collection LI-RADS 5RSNA Case Collection2022Radioembolization of Liver Metastasis RSNA Case Collection2020Hepatic AdenomatosisRSNA Case Collection2021 Vol. 293, No. 3 Metrics Altmetric Score PDF download
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
11秒前
zyh发布了新的文献求助10
14秒前
搜集达人应助zyh采纳,获得10
24秒前
量子星尘发布了新的文献求助10
43秒前
GPTea完成签到,获得积分0
1分钟前
kiterunner发布了新的文献求助10
1分钟前
文静灵阳完成签到 ,获得积分10
1分钟前
fufufu123完成签到 ,获得积分10
2分钟前
2分钟前
dolabmu完成签到 ,获得积分10
2分钟前
胡国伦完成签到 ,获得积分10
2分钟前
面汤完成签到 ,获得积分10
2分钟前
ljlwh完成签到 ,获得积分10
3分钟前
3分钟前
3分钟前
颜枫莹完成签到,获得积分10
3分钟前
3分钟前
3分钟前
Lucas应助科研通管家采纳,获得10
4分钟前
4分钟前
Wei发布了新的文献求助10
4分钟前
4分钟前
玛琳卡迪马完成签到,获得积分10
4分钟前
5分钟前
5分钟前
大模型应助康康XY采纳,获得10
6分钟前
6分钟前
6分钟前
6分钟前
康康XY发布了新的文献求助10
6分钟前
6分钟前
6分钟前
lee完成签到 ,获得积分10
6分钟前
Milo完成签到,获得积分10
7分钟前
月军完成签到 ,获得积分10
7分钟前
康康XY完成签到 ,获得积分10
7分钟前
研友_nxw2xL完成签到,获得积分10
8分钟前
muriel完成签到,获得积分0
8分钟前
Orange应助科研通管家采纳,获得10
8分钟前
如歌完成签到,获得积分10
8分钟前
高分求助中
Comprehensive Toxicology Fourth Edition 24000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Pipeline and riser loss of containment 2001 - 2020 (PARLOC 2020) 1000
World Nuclear Fuel Report: Global Scenarios for Demand and Supply Availability 2025-2040 800
Handbook of Social and Emotional Learning 800
Risankizumab Versus Ustekinumab For Patients with Moderate to Severe Crohn's Disease: Results from the Phase 3B SEQUENCE Study 600
Lloyd's Register of Shipping's Approach to the Control of Incidents of Brittle Fracture in Ship Structures 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 5138384
求助须知:如何正确求助?哪些是违规求助? 4337758
关于积分的说明 13511864
捐赠科研通 4176684
什么是DOI,文献DOI怎么找? 2290284
邀请新用户注册赠送积分活动 1290727
关于科研通互助平台的介绍 1232767